Association Between Delivery Method and Offspring's Risk of Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

Association Between Delivery Method and Offspring's Risk of Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta-Analysis

  • By

  • Hana Taha

  • Mohammad Al-Shalalfeh

  • Almothana Khalil

  • Yumna Khasawneh

  • Aseel Abu Ata

  • Hala AbuEin

  • Ahmad Issa

  • Taher Alhawamdeh

  • Mishkah BaniMustafa

  • Mohammed Qussay Al-Sabbagh

  • Linus Jönsson

  • April 8, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Epidemiology
    • Microbiome Research

  • #2

    University of Copenhagen
    University of Copenhagen

    Copenhagen, Capital Region

    Key Differentiators

    • Gastroenterology
    • Epidemiology
    • Pediatrics

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Microbiome Science
    • Epidemiology

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Epidemiology
    • Gastroenterology
    • Public Health

Original Source(s)

Association Between Delivery Method and Offspring's Risk of Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta-Analysis

  • by Hana Taha, Mohammad Al-Shalalfeh, Almothana Khalil, Yumna Khasawneh, Aseel Abu Ata, Hala AbuEin, Ahmad Issa, Taher Alhawamdeh, Mishkah BaniMustafa, Mohammed Qussay Al-Sabbagh, Linus Jönsson

  • April 8, 2026

Related Content

Ethosuximide vs Placebo for IBS Pain

Randomized trial found no improvement in abdominal pain and higher discontinuation rates with the calcium channel blocker.

Renal Conditions Associated with Inflammatory Bowel Disease: Exploring Clinical Links, Shared Mechanisms, and Management Approaches

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management